Viromed Medical AG Announces Capital Increase Through Cash Contribution

Viromed Medical AG has decided to implement a capital increase through a cash contribution, excluding existing shareholders' subscription rights. The decision, approved by the Supervisory Board, was taken on October 26, 2026. The company aims to raise its share capital from EUR 21,250,000 to EUR 21,700,000 by issuing 450,000 new shares at a price of EUR 4.50 each.

The new shares will be initially subscribed by Small & Mid Cap Investmentbank AG, Munich, before being offered to selected investors through a private placement. This move is expected to generate gross proceeds of EUR 2 million, which Viromed plans to use to finance its working capital needs.

Uwe Perbandt, the CEO of Viromed Medical AG, disclosed this information, signaling strategic financial maneuvering to support the company's operations.